Sudeep Pharma

SUDEEPPHRM

Q: How strong is Sudeep Pharma balance sheet?

Balance sheet of Sudeep Pharma is strong.It shouldn't have solvency or liquidity issues.

Q: Is the debt of Sudeep Pharma increasing or decreasing?

Yes, The net debt of Sudeep Pharma is increasing.Latest net debt of Sudeep Pharma is ₹73.33 Crs as of Sep-25.This is greater than Mar-25 when it was ₹31.26 Crs.

Q: Is Sudeep Pharma stock expensive?

Sudeep Pharma is not expensive.Latest PE of Sudeep Pharma is 48.76, while 3 year average PE is 51.6. Also latest EV/EBITDA of Sudeep Pharma is 31.33 while 3yr average is 34.17.

Price

Small Cap

₹6,592 Cr.

New to Zerodha? Sign-up for free.

Sudeep Pharma Limited, incorporated in 1989, is a global manufacturer of pharmaceutical excipients, food-grade minerals and specialty nutrition ingredients. It runs extensive facilities, offers a wid… More

Sudeep Pharma Limited, incorporated in 1989, is a global manufacturer of pharmaceutical excipients,… More

Low

524

52W Range

High

795

47.53

Sector PE

25.95

P/B

9.1

Div.Yield

ROE

28.13%

EBIDTA

30.55

ROCE

35.0

EPS

4.2

New to Zerodha? Sign-up for free.

Get instant stock alerts

Share Price
Financials
Revenue mix
Shareholdings
Peers
Forensics

Coming soon

Summary
Profit & Loss
Balance sheet
Cashflow

Yearly | Quarterly

View Detailed Summary

This data is currently unavailable for this company.

Yearly | Quarterly

(In Cr.)

(In Cr.)
This data is currently unavailable for this company.

Financial Ratio's

(In %)

Detailed P&L Report

(In Cr.)

Detailed Balance Sheet

Financial Year (In Cr.)

Detailed Cash Flow

Product wise
Location wise

SUDEEPPHRM
Revenue Mix

Latest

Historic

This data is currently unavailable for this company.

SUDEEPPHRM
Revenue Mix

Latest

Historic

This data is currently unavailable for this company.

More Info

Shareholdings

Holders

Detailed Shareholdings

This data is currently unavailable for this company.

Peers

Detailed Peers

Forensics

View Detailed Forensics

Recent events

News
Corporate Actions

India's Sudeep Pharma jumps 33% in trading debut

Nov 28, 2025

Events:

Lockin Period Expiry (Anchor)

Date

Feb 24, 2026

Quarterly Results

Announcement Date

Feb 06, 2026

Lockin Period Expiry (Anchor)

Date

Dec 26, 2025

Quarterly Results

Announcement Date

Dec 19, 2025

More Small Cap Ideas

See similar 'Small' cap companies with recent activity

Promoter Buying

Companies where the promoters are bullish

Detailed List

Capex

Companies investing on expansion

Detailed List

Superstar Investor

Companies where well known investors have invested

Detailed List

Popular questions

Business
Financials
Share Price
Shareholdings

What does Sudeep Pharma do?

Sudeep Pharma along with its subsidiary companies is engaged in business of manufacturing of excipients and specialty ingredients for the pharmaceutical, food and nutrition industries and is dedicated to contributing to the global healthcare ecosystem by providing excipients and specialty ingredients. It develops solutions that enhance vitality, functionality, and efficiency in consumer products.

Who are the competitors of Sudeep Pharma?

Sudeep Pharma major competitors are Blue Jet Healthcare, Anlon Healthcare, Acutaas Chemicals, Kronox Lab Sciences. Market Cap of Sudeep Pharma is ₹6,762 Crs. While the median market cap of its peers are ₹3,642 Crs.

Is Sudeep Pharma financially stable compared to its competitors?

Sudeep Pharma seems to be financially stable compared to its competitors. The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

Does Sudeep Pharma pay decent dividends?

The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Sudeep Pharma latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

How has Sudeep Pharma allocated its funds?

Companies resources are allocated to majorly unproductive assets like Inventory

How strong is Sudeep Pharma balance sheet?

Balance sheet of Sudeep Pharma is strong. It shouldn't have solvency or liquidity issues.

Is the profitablity of Sudeep Pharma improving?

Yes, profit is increasing. The profit of Sudeep Pharma is ₹172 Crs for TTM, ₹139 Crs for Mar 2025 and ₹133 Crs for Mar 2024.

Is the debt of Sudeep Pharma increasing or decreasing?

Yes, The net debt of Sudeep Pharma is increasing. Latest net debt of Sudeep Pharma is ₹73.33 Crs as of Sep-25. This is greater than Mar-25 when it was ₹31.26 Crs.

Is Sudeep Pharma stock expensive?

Sudeep Pharma is not expensive. Latest PE of Sudeep Pharma is 48.76, while 3 year average PE is 51.6. Also latest EV/EBITDA of Sudeep Pharma is 31.33 while 3yr average is 34.17.

Has the share price of Sudeep Pharma grown faster than its competition?

There is not enough historical data for the companies share price.

Is the promoter bullish about Sudeep Pharma?

Promoters stake in the company seems stable, and we need to go through filings and allocation of resources to gauge promoter bullishness. Latest quarter promoter holding in Sudeep Pharma is 76.15% and last quarter promoter holding is 76.15%.

Are mutual funds buying/selling Sudeep Pharma?

The mutual fund holding of Sudeep Pharma is increasing. The current mutual fund holding in Sudeep Pharma is 5.67% while previous quarter holding is 3.44%.

SUDEEPPHRM

Share Price

Financials

Revenue mix

Shareholdings

Peers

Forensics

Summary

Profit & Loss

Balance sheet

Cashflow

Product wise

Location wise

Recent events

News

Corporate Actions

India's Sudeep Pharma jumps 33% in trading debut

Events:

Lockin Period Expiry (Anchor)

Quarterly Results

Lockin Period Expiry (Anchor)

Quarterly Results

More Small Cap Ideas

Promoter Buying

Capex

Superstar Investor

Popular questions

Business

Financials

Share Price

Shareholdings

What does Sudeep Pharma do?

Who are the competitors of Sudeep Pharma?

Is Sudeep Pharma financially stable compared to its competitors?

Does Sudeep Pharma pay decent dividends?

How has Sudeep Pharma allocated its funds?

How strong is Sudeep Pharma balance sheet?

Is the profitablity of Sudeep Pharma improving?

Is the debt of Sudeep Pharma increasing or decreasing?

Is Sudeep Pharma stock expensive?

Has the share price of Sudeep Pharma grown faster than its competition?

Is the promoter bullish about Sudeep Pharma?

Are mutual funds buying/selling Sudeep Pharma?